Latest News - Personnel/Company News

Monday, March 06, 2017 | Acquisitions and Mergers, Personnel/Company News,

Pierre Fabre and Hill Dermaceuticals Partner in Commercial Partnership for TOLAK for AKs

Pierre Fabre Dermo-Cosmetique and Hill Dermaceuticals, Inc. have entered into a strategic commercial partnership for TOLAK, a patented prescription dermatologic drug, indicated for the topical treatme…

Read the full story

Saturday, March 04, 2017 | Personnel/Company News,, Zeltiq

Zeltiq Shines Spotlight on CoolAdvantage Petite Applicator at AAD Annual Meeting

ZELTIQ® Aesthetics is showcasing the CoolAdvantage Petite™ applicator at the American Academy of Dermatology Annual Meeting (AAD) in Orlando.  The CoolAdvantage technology is the o…

Read the full story

Thursday, March 02, 2017 | Personnel/Company News,, Galderma, Modernizing Medicine

Modernizing Medicine and Galderma Team Up to Offer Integrated OTC eCommerce Platform

Specialty-specific health information technology company Modernizing Medicine, Inc. and Galderma Laboratories, L.P. are collaborating to deliver new capabilities in support of improved patient experie…

Read the full story

Thursday, March 02, 2017 | Business of Medicine, Healthcare Trends, Personnel/Company News,, Galderma

Galderma and Colorescience Launch Collaboration

Galderma will collaborate with Colorescience to expand skincare solutions to individuals who seek innovative daily skincare products that can be used in conjunction with traditional facial injectable …

Read the full story

Thursday, February 23, 2017 | Personnel/Company News, Product Launches and Updates, Obagi, Valeant NJ

Obagi Medical Products Collaborates with Suzan Obagi, MD and Nextcell Medical to Introduce New Line

Valeant Pharmaceuticals International, Inc.’s wholly owned subsidiary Obagi Medical Products collaborated with Nextcell Medical Company to claim exclusive distribution of Suzan Obagi, MD’s…

Read the full story

Monday, February 20, 2017 | Personnel/Company News,

Suzanne Olbricht, MD, Named New Chief of Dermatology at Beth Israel Deaconess Medical Center

Suzanne Olbricht, MD, is the new Chief of Dermatology at Beth Israel Deaconess Medical Center (BIDMC) in Boston. She will also serve as President of the American Academy of Dermatology in 2018. …

Read the full story

Tuesday, February 14, 2017 | Personnel/Company News,, Cosmeceuticals, Revision Skincare

Ray Canole is New Chief Commercial Officer at Revision Skincare

Revision Skincare has announced the appointment of Ray Canole to the position of Chief Commercial Officer. He has over 15 years of business development and commercial related experience in d…

Read the full story

Tuesday, February 14, 2017 | Acquisitions and Mergers, Personnel/Company News,, Cosmetic surgery, Cynosure

Hologic to Acquire Cynosure

Hologic, Inc.  and Cynosure, Inc. have signed a definitive agreement for Hologic to acquire all outstanding Cynosure shares for $66.00 per share in cash, which corresponds to an eq…

Read the full story

Friday, February 10, 2017 | Personnel/Company News

Crescita Therapeutics Announces Management and Board Changes

Crescita Therapeutics Inc., a commercial dermatology company with a portfolio of over-the-counter and prescription products for the treatment and care of skin diseases and their symptoms, introduced M…

Read the full story

Wednesday, February 01, 2017 | Healthcare Trends, Personnel/Company News,,, Research and Publications

Medical Spa State of the Industry Statistical Study Now Open

During the past five years, the medical spa industry has grown and evolved to a point where it has become one of the most exciting and lucrative new industries in the country. Because of this, it is n…

Read the full story

Wednesday, February 01, 2017 | Personnel/Company News, Valeant NJ

Valeant Dermatology to Award $10,000 Scholarships for Undergraduate and Graduate Degrees

Valeant Dermatology, a division of Valeant Pharmaceuticals North America LLC, will award nine individual scholarships of up to $10,000 through its annual ASPIRE HIGHER Scholarship Program. The scholar…

Read the full story

Friday, January 27, 2017 | Personnel/Company News, Phase 3/4 Trials,, Research and Publications, Novan

Topline Results from Novan's SB204 Phase 3 Pivotal Trials: Inconsistent Across Trials

Novan, Inc. (NASDAQ:NOVN) today announced  top-line results from the Company’s two, replicate Phase 3 pivotal clinical trials for SB204 in the treatment of acne vulgaris. In the intent-to-t…

Read the full story

Monday, January 23, 2017 | Personnel/Company News,, BioPharmX Corporation, BioPharmX Corporation

Specialty Pharma Industry Vet Charles Gregory Vontz Joins BioPharmX Board of Directors

Charles "Greg" Vontz  is joining rhe Board of Directors of BioPharmX Corporation as an independent director, effective as of Jan. 17.  Vontz's appointment expands the board …

Read the full story

Wednesday, January 18, 2017 | Personnel/Company News,,

First Patient Treated in Dermata Therapeutics Phase 2 Acne Rosacea Clinical Study

The first patient has been dosed in Dermata Therapeutics’s Phase 2 acne rosacea study of DMT210, a topical gel specifically developed to downregulate the proinflammatory cytokines in the skin re…

Read the full story

Tuesday, January 17, 2017 | Personnel/Company News,,, Research and Publications, ISDIN

ISDIN: Broad Spectrum Sun Protection Cream with DNA Repair Beneficial Post AK Treatment

ISDIN has reported promising results of a 9-month, randomized, investigator-blinded parallel-group study in a poster presentation at the Winter Clinical Conference. The study was design…

Read the full story
Load More